非择期胆囊切除术结局与术式十年趋势(2015-2024)
该回顾性队列研究纳入ACS-NSQIP 2015-2024年231,048例非择期胆囊切除术成人患者,评估短期结局与术式的十年变化。调整后30天死亡率、再手术率、主要并发症和住院时间均显著下降,微创手术比例上升,但手术部位感染尤其是器官/腔隙感染显著增加。
要点
- 非择期胆囊切除术调整后死亡率、再手术率、主要并发症及住院时间十年间显著下降。
- 微创手术比例从91.53%升至97.95%,机器人利用率2022-2024年从1.78%升至13.57%。
- 手术部位感染调整后从1.68%升至3.52%,主要由器官/腔隙感染增加驱动。
核心结论
- 2015-2024年全国非择期胆囊切除术调整后死亡率、再手术率、主要并发症和住院时间显著下降,微创手术利用率增加。
- 同期器官/腔隙手术部位感染上升,构成需进一步研究的重要反向 morbidity 趋势。
研究设计与样本
- 回顾性队列研究,纳入ACS-NSQIP 2015-2024年231,048例成人非择期胆囊切除术,排除择期手术、ASA 5级及同期手术。
- 采用稳健方差泊松回归评估时间趋势,模型调整术式、ASA分组、性别、年龄、BMI、西班牙裔、高血压、糖尿病、COPD、CHF、出血性疾病和手术时间。
主要发现
- 调整后30天死亡率从2015年0.59%降至2024年0.38%(相对下降34.8%;P<0.001)。
- 调整后再手术率从1.54%降至1.14%(相对下降26.2%;P<0.001)。
- 调整后主要并发症从6.77%降至5.41%(相对下降20.1%;P<0.001)。
- 调整后平均住院时间从3.71天降至2.97天(相对下降19.9%;P<0.001)。
- 微创手术从91.53%升至97.95%;机器人利用率从2022年1.78%升至2024年13.57%。
临床怎么用
- 非择期胆囊切除术中微创术式应用增加与短期结局改善相关,支持继续推广微创技术。
- 需关注器官/腔隙手术部位感染的上升趋势,加强术后感染监测与防控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contemporary national trends in outcomes and operative approach after non-elective cholecystectomy remain incompletely characterized. We evaluated 10-year changes in short-term outcomes and operative approach. STUDY DESIGN: This retrospective cohort study identified 231,048 adults undergoing non-elective cholecystectomy in ACS-NSQIP from 2015-2024, excluding elective procedures, ASA class 5, and concurrent procedures. Poisson regression with robust variance evaluated temporal trends. Models adjusted for operative approach, ASA group, sex, age, BMI, Hispanic ethnicity, hypertension, diabetes, COPD, CHF, bleeding disorder, and operative time. RESULTS: Adjusted 30-day mortality decreased from 0.59% in 2015 to 0.38% in 2024 (34.8% relative decrease; P<0.001), reoperation from 1.54% to 1.14% (26.2%; P<0.001), and major complications from 6.77% to 5.41% (20.1%; P<0.001). Adjusted mean length of stay decreased from 3.71 to 2.97 days (19.9%; P<0.001). Minimally invasive surgery increased from 91.53% to 97.95%; robotic utilization increased from 1.78% in 2022 to 13.57% in 2024. Conversely, adjusted surgical-site infection increased from 1.68% to 3.52%, driven primarily by organ/space infection (1.02% to 2.59%; P<0.001). CONCLUSIONS: Nationally, non-elective cholecystectomy was associated with substantial reductions in adjusted mortality, reoperation, major complications, and length of stay from 2015-2024 as minimally invasive utilization increased. The concurrent rise in organ/space surgical-site infection identifies an important countervailing morbidity trend requiring further investigation.
引用
- Filardi K, Kim P, Gates J, et al. National Trends in Outcomes and Operative Approach After Non-Elective Cholecystectomy, 2015-2024. J Am Coll Surg. 2026. PMID: 42803494. doi:10.1097/XCS.0000000000002188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。